SCHEMBL3391787

SCHEMBL3391787

CNC(SCc1ccccc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.50
PPARA Q07869 2/20 0.50
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 1/20 0.41
LMNA P02545 1/20 0.41
CYP2C19 P33261 1/20 0.41
ACE P12821 1/20 0.40
TAAR1 Q96RJ0 2/20 0.40
SLC18A2 Q05940 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9784984 0.80 PPARG (0.52) PPARGPPARANPSR1L3MBTL1ATM
SCHEMBL11640433 0.78 PPARG (0.47) PPARGPPARANPSR1L3MBTL1ATM
SCHEMBL44800 0.76 L3MBTL1 (0.56) PPARGPPARANPSR1L3MBTL1ATM
SCHEMBL6954426 0.75 PPARG (0.49) PPARGPPARAL3MBTL1ATMPOLB
SCHEMBL11637402 0.74 PPARA (0.54) PPARGPPARAATMSMN1; SMN2CYP1A2
SCHEMBL3294142 0.73 PPARG (0.47) PPARGPPARANPSR1L3MBTL1ATM
SCHEMBL6991601 0.73 EPHX1 (0.53) PPARGPPARANPSR1L3MBTL1ATM
SCHEMBL7050743 0.73 POLB (0.51) PPARGPPARANPSR1L3MBTL1ATM
SCHEMBL8997911 0.72 ACE (0.62) PPARGPPARAACE
SCHEMBL5217215 0.72 ACE (0.62) PPARGPPARAACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560558-B1 USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH LG HOUSEHOLD & HEALTH CARE LTD (KR) 2010-12-29 EP claimed
EP-1560558-A4 USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH LG HOUSEHOLD & HEALTH CARE LTD (KR) 2008-09-24 EP claimed
JP-2006508103-A 2006-03-09 JP claimed
US-6987090-B2 Use of 3-position cyclosporin derivatives for hair growth LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2006-01-17 US claimed
EP-1560558-A1 USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH LG Household & Health Care Ltd. (KR) 2005-08-10 EP claimed
WO-2004041221-A1 USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2004-05-21 WO claimed
US-20040087496-A1 Use of 3-position cyclosporin derivatives for hair growth LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2004-05-06 US claimed
EP-1560558-B1 USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH LG HOUSEHOLD & HEALTH CARE LTD (KR) 2010-12-29 EP disclosed
EP-1560558-A4 USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH LG HOUSEHOLD & HEALTH CARE LTD (KR) 2008-09-24 EP disclosed
US-6987090-B2 Use of 3-position cyclosporin derivatives for hair growth LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2006-01-17 US disclosed
EP-1560558-A1 USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH LG Household & Health Care Ltd. (KR) 2005-08-10 EP disclosed
WO-2004041221-A1 USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2004-05-21 WO disclosed
US-20040087496-A1 Use of 3-position cyclosporin derivatives for hair growth LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087496-A1 Use of 3-position cyclosporin derivatives for hair growth TPMT, BHMT2, SUCLG1 PPARG 4750/4885PPARA 4553/4885NPSR1 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.